These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25633517)

  • 41. [Prostate carcinoma--18F-choline-PET/CT for relapse].
    Ruchalla E
    Rofo; 2014 Jan; 186(1):14-5. PubMed ID: 24511606
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.
    Hausmann D; Bittencourt LK; Attenberger UI; Sertdemir M; Weidner A; Büsing KA; Brade J; Wenz F; Schoenberg SO; Dinter DJ
    Clin Nucl Med; 2014 Mar; 39(3):e197-201. PubMed ID: 24092230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Zengerling F; Schrader AJ; Schrader M; Jentzmik F
    Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Rager O; Baskin A; Amzalag G; Buchegger F; Miralbell R; Ratib O; Zilli T; Garibotto V
    Nuklearmedizin; 2015; 54(5):211-6. PubMed ID: 26213186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unexpected diagnosis of peripheral schwannoma on 18F-fluoroethylcholine PET/CT for localization of prostate cancer recurrence and biopsy under real-time PET/ultrasound fusion guidance.
    Freesmeyer M; Drescher R; Winkens T
    Clin Nucl Med; 2014 Apr; 39(4):385-6. PubMed ID: 24561678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors.
    Bochev P; Klisarova A; Kaprelyan A; Chaushev B; Dancheva Z
    Hell J Nucl Med; 2012; 15(2):125-9. PubMed ID: 22741148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
    Mertens K; Slaets D; Lambert B; Acou M; De Vos F; Goethals I
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2188-93. PubMed ID: 20544193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients.
    Beheshti M; Langsteger W
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):910-1; author reply 912-3. PubMed ID: 22258711
    [No Abstract]   [Full Text] [Related]  

  • 50. Unexpected detection of brain metastases by 18F-NaF PET/CT in a patient with lung cancer.
    Wu J; Zhu H; Ji H
    Clin Nucl Med; 2013 Nov; 38(11):e429-32. PubMed ID: 23877510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skeletal "Superscan" on 18F-Choline PET/CT: Cases of Myeloproliferative Disease.
    Dias AH; Bouchelouche K
    Clin Nucl Med; 2016 Mar; 41(3):e173-4. PubMed ID: 26595339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer.
    Evangelista L; Pasquale R
    Clin Nucl Med; 2016 Sep; 41(9):746. PubMed ID: 26975019
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
    Dejust S; Messaoud L; Jallerat P; Marical V; Morland D
    Clin Nucl Med; 2018 Oct; 43(10):780-781. PubMed ID: 30153155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT.
    De Leiris N; Ruggeri V; Riou L; Laramas M; Djaileb L
    Clin Nucl Med; 2021 Feb; 46(2):e116-e117. PubMed ID: 33181748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual F-18 choline uptake in penile metastasis from prostate cancer.
    Hodolič M; Fettich J; Cimitan M; Kragelj B; Goldsmith SJ
    Clin Nucl Med; 2012 Apr; 37(4):e89-90. PubMed ID: 22391732
    [No Abstract]   [Full Text] [Related]  

  • 56. Incidental Neurofibroma on 18F-Fluorocholine PET/MR.
    Agrawal K; Sajjan RS; Gavra M; Fraioli F; Bomanji J; Syed R
    Clin Nucl Med; 2015 Sep; 40(9):e455-6. PubMed ID: 26018694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ¹⁸Fluorocholine PET/CT in parathyroid carcinoma: a new tool for disease staging?
    Deandreis D; Terroir M; Al Ghuzlan A; Berdelou A; Lacroix L; Bidault F; Troalen F; Hartl D; Lumbroso J; Baudin E; Schlumberger M; Leboulleux S
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1941-2. PubMed ID: 26253272
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT.
    Bieze M; van Gulik TM; Bennink RJ
    Clin Nucl Med; 2013 Feb; 38(2):e80-2. PubMed ID: 23334143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate Cancer.
    Cegla P; Kubiak A; Witkowska K; Czepczyński R
    Clin Nucl Med; 2020 Jul; 45(7):575-576. PubMed ID: 32433169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidental Detection of Plasma Cell Neoplasm on 18F-Choline PET/CT Imaging.
    Paudel J; Singla N; Bhattacharya A; Basher RK; Mittal BR
    Clin Nucl Med; 2019 Feb; 44(2):140-141. PubMed ID: 30562192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.